Similar Papers

Paper Title
Journal
Date
Author
1356P - Increase in S100B and LDH as early outcome predictors for non-responsiveness to anti-PD-1 monotherapy in advanced melanoma
E.A Rozeman ... H Van Rossum
Annals of Oncology | VOL. 30
E.A Rozeman, et. al.E.A Rozeman ... H Van Rossum
01 Oct 2019
Diagnostic performance of early increase in S100B or LDH as outcome predictor for non-responsiveness to anti-PD-1 monotherapy in advanced melanoma
Elisa A Rozeman ... Huub H Van Rossum
Clinica Chimica Acta | VOL. 533
Elisa A Rozeman, et. al.Elisa A Rozeman ... Huub H Van Rossum
13 Jun 2022
Serum concentration of NSE and S-100b during LVAD in non-resuscitated patients
Rüdiger Pfeifer ... Hans R Figulla
Resuscitation | VOL. 79
Rüdiger Pfeifer, et. al.Rüdiger Pfeifer ... Hans R Figulla
09 Jul 2008
Clinical activity of fianlimab (REGN3767), a human anti-LAG-3 monoclonal antibody, combined with cemiplimab (anti-PD-1) in patients (pts) with advanced melanoma.
Omid Hamid ...
Journal of Clinical Oncology | VOL. 39
Omid Hamid, et. al.Omid Hamid ...
20 May 2021
View more papers

More From: Clinica Chimica Acta

Paper Title
Journal
Date
Author
Clinicopathological characteristics of patients with low titer anti-phospholipase A2 receptor antibodies verified by indirect immunofluorescence assay
Hao-Yuan Cui ... Li-Meng Chen
Clinica Chimica Acta | VOL. 567
Hao-Yuan Cui, et. al.Hao-Yuan Cui ... Li-Meng Chen
01 Feb 2025
MiR-363: A potential biomarker of kidney diseases
Yiqi Huang ... Lili Liu
Clinica Chimica Acta | VOL. 567
Yiqi Huang, et. al.Yiqi Huang ... Lili Liu
01 Feb 2025
Editorial Board
-
Clinica Chimica Acta | VOL. -
--
01 Feb 2025
Predictive biomarkers of pancreatic cancer metastasis: A comprehensive review
Mengting Chen ... Yun Qian
Clinica Chimica Acta | VOL. -
Mengting Chen, et. al.Mengting Chen ... Yun Qian
01 Feb 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.